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Abstract
Extracranial metastases from brain meningiomas is a rare, but well-documented entity. Metastases
occur mostly in the lungs, pleura and liver, but may also affect lymph nodes and bones. We report
here on a patient who was treated for an atypical brain meningioma with multiple surgeries and
multiple sessions of stereotactic radiosurgery with good control of his brain disease. Thirteen years
after diagnosis, he developed bilateral large sacroiliac and abdominal metastases.
Introduction
Meningioma is a common intracranial tumor. Most men-
ingiomas are benign slowly growing tumors that histolog-
ically correspond to World Health Organization (WHO)
grade I. However, atypical (WHO grade II) and anaplastic
(WHO grade III) meningiomas show a more aggressive
biological behavior with a high risk of local recurrence
and a less favorable prognosis. Extracranial dissemination
of meningiomas has been rarely reported. We present here
an unusual case of a patient who was treated for an atypi-
cal brain meningioma originally diagnosed in 1994 and
treated by multiple surgical resections, several courses of
stereotactic radiosurgery and radiotherapy, and a course
of whole-brain radiotherapy with good control of his cra-
nial disease. His disease remained confined to the brain
for thirteen years, after which he developed bilateral large
sacroiliac and abdominal metastases.
Case presentation
The patient is a 45-year-old man who was admitted for the
first time in 1994 at the age of 31 for persistent headache.
Work-up revealed a large left tentorial meningioma. He
had no history of cranial radiation during childhood or
clinical features of neurofibromatosis type I or II. He
underwent gross total surgical resection. Pathologic evalu-
ation, which was recently re-reviewed, showed an atypical
meningioma with the following features: hypercellularity
with sheets of monotonous meningothelial cells display-
ing a prominent mitotic activity with around 4 mitoses
per 10 high power fields. In May of 1997, follow-up brain
MRI revealed a recurrence in the vicinity of the original
tumor bed. Surgery was performed with gross total tumor
removal. Pathologic evaluation again showed meningi-
oma with similar pathologic features. In September 1999,
he developed multiple small tumor recurrences in the
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parietal, occipital and cerebellar lobes for which he under-
went stereotactic radiosurgery (SRS) with excellent results
on tumor control. In September 2001, the patient devel-
oped additional recurrent lesions in multiple sites in the
infratentorial, retroclival, left optic nerve sheet, and
foramen magnum regions.
He was again treated by stereotactic radiosurgery with
good tumor control defined as a complete disappearance
or progressive decrease in lesion size. In June 2003, he
received further SRS treatment to new cerebellar, premed-
ullary and craniocervical junction lesions. In February
2004, he developed numerous lesions outside previously
treated sites and was given whole brain radiation therapy
(WBRT) of 36 Gy as a palliative therapy because of the
multiplicity and the progression of the brain lesions. Sur-
prisingly many of the small lesions disappeared after
WBRT and the patient remained asymptomatic until
August 2005 when he developed left facial numbness.
Brain MR imaging at that time showed a recurrent lesion
in the left cerebellopontine (CP) angle, an area that was
previously treated by SRS and WBRT. He was given 10 ses-
sions of stereotactic radiotherapy (30 Gy in 10 fractions)
and achieved a good partial response but this lesion grew
back and caused progressive left facial numbness due to
left Vth nerve compression. This was treated by another
craniotomy and surgical resection. Histopathologic exam-
ination showed meningioma with the same pathologic
features and additional elements like the presence of foci
of geographic necrosis and a hemangiopericytomatous
pattern of vasculature (Figure 1A). Mitotic count was now
up to five per ten high power fields and Ki-67 labeling
index was up to 15% (Figure 1B). The tumor was focally
positive for epithelial membrane antigen (EMA) and neg-
ative for CD31 and CD34. The lack of CD34 immunos-
taining excluded the possibility of hemangiopericytoma
or solitary fibrous tumor of the meninges. Occasional
cells were weakly positive for S-100 protein. In July 2007,
follow-up MRI showed tumor progression at the same CP
angle site for which a redo SRS treatment was debated and
finally delivered without significant acute toxicity. Of
note, the question of chemotherapy was raised many
times but the patient refused to receive any systemic ther-
apy.
In November 2007 and because of persistent low back
pain, the patient underwent MRI of the spine and pelvis.
These showed two large masses in the left and right sacro-
iliac and gluteus muscle regions measuring 11 × 9 cm and
8 × 7 cm, respectively, causing bone destruction of the left
sacral wing with extension in the left sacral neural
foramina (Figure 2A). Surgical biopsy was performed and
this revealed metastatic atypical meningioma, with simi-
lar characteristics to its intracranial counterparts. Further
work-up included CT scan of the abdomen which revealed
large bilateral renal metastases (Figure 2B). CT of the chest
was negative. The patient was evaluated by medical oncol-
ogy but declined systemic chemotherapy. Brain MRI
showed no disease progression. He is now receiving palli-
ative care for pain control.
Discussion
Meningioma is a common intracranial tumor that
accounts for 14 to 19% of all primary intracranial neo-
plasms [1]. It is generally a benign tumor, but recurrence
is not uncommon notably for atypical and anaplastic var-
iants. A report by the World Health Organization indi-
cated that 94.3% of meningiomas are benign with a 5-year
recurrence rate of 3% compared to 38% and 78% for atyp-
ical and anaplastic meningiomas, respectively [2]. Distant
metastases from benign meningiomas are extremely rare
and almost all of the reported cases were associated with
a large intracranial tumor [3]. On the other hand, the rate
of distant metastases could reach 5% for atypical and 30%
for anaplastic or malignant meningiomas [4].
Several histologic parameters have been identified as indi-
cators of aggressive behavior and predictors of rapid recur-
rence of meningiomas. These include high cellularity,
mitotic rate, nuclear pleomorphism, presence of foci of
necrosis, and invasion of adjacent structures [5-9]. Other
reported prognostic indicators of tumor recurrence
include change in histologic morphology, malignant
transformation, cellular heterogeneity, and multicentric-
ity [10,11]. In the case presented here, atypical histologic
features such as hypercellularity, relatively increased
mitotic rate (4 mitoses per 10 high power fields), high
proliferation index, and multicentricity were present.
(A) H&E stain on the intracranial specimen resected in 2007  showing high cellularity and sheets of meningothelial cells  with a mitotic activity of 4 per 10 high power fields with foci  of necrosis (center and lower right) Figure 1
(A) H&E stain on the intracranial specimen resected 
in 2007 showing high cellularity and sheets of menin-
gothelial cells with a mitotic activity of 4 per 10 high 
power fields with foci of necrosis (center and lower 
right). (B) Ki-67 immunostaining with the MIB-1 antibody 
showing a labeling index of around 15%.Radiation Oncology 2009, 4:20 http://www.ro-journal.com/content/4/1/20
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According to one report, tumors that did metastasize usu-
ally had histologic features consistent with a malignant
phenotype, such as focal necrosis, brain invasion, cellular
pleomorphism, and frequent mitoses [12]. Meningiomas
may disseminate through hematogenous, lymphatic, or
cerebrospinal fluid routes [13]. The most common path-
way of metastasis in meningiomas is considered to be
through the cerebrospinal fluid but this does not explain
extraneural metastases [14-16]. The other mode of meta-
static spread occurs through the passage of tumor cells
into venous channels and spread through the right blood
circulation into the lungs, pleura, and other organs
[17,18]. Isolated hepatic or renal metastasis may occur
through the vertebral (meningorachidian) venous sys-
tem[19]. These vertebral veins have several connections
with the veins of the skull, spinal canal, vertebral column,
and the intercostal veins of the thoracoabdominal wall.
The role of chemotherapy is limited in meningioma; there
are no or limited proven benefit from any systemic ther-
apy and no clear drug or combination regimen that has
given consistent responses.
In order of descending frequency, metastases from menin-
giomas occur in the lungs and pleura, liver, lymph nodes,
and bone [20]. Our patient had metastatic lesions in both
sacroiliac regions and in both kidneys with remarkable
symmetry in these locations. Sacral metastases from
benign intracranial meningiomas are rare occurrences and
could only be found in two reports [21,22]. However,
renal metastases from meningiomas have been reported
more often and constituted in one report 8% of all metas-
tases from intracranial benign and malignant meningi-
omas [23]. We could not find any report with description
of symmetrical features in meningioma metastases.
In conclusion, we report here the case of a 45-year-old
man who developed bilateral sacroiliac and renal metas-
tases from a recurrent intracranial meningioma of atypical
histology 13 years after initial diagnosis.
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(A) Axial MRI images showing bilateral sacroiliac heterogeneously enhancing masses Figure 2
(A) Axial MRI images showing bilateral sacroiliac heterogeneously enhancing masses. (B) Abdominal CT scan 
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